» Articles » PMID: 15243936

Immune Response to Postprimary Tuberculosis in Mice: Mycobacterium Tuberculosis and Miycobacterium Bovis Bacille Calmette-Guérin Induce Equal Protection

Overview
Journal J Infect Dis
Date 2004 Jul 10
PMID 15243936
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We addressed the question of whether protective immunity induced by natural infection with Mycobacterium tuberculosis and that induced by vaccination with Mycobacterium bovis bacille Calmette-Guerin (BCG) differ in the murine model. We infected mice with M. tuberculosis Erdman, cured them by chemotherapy, and subsequently reinfected them with a low dose of M. tuberculosis H37Rv. The course of tuberculosis was compared with that in mice previously vaccinated with BCG Danish 1331. Protection against postprimary M. tuberculosis infection did not differ significantly between the 2 groups. After challenge infection, numbers of interferon- gamma -positive splenocytes did not differ between mice with primary infection and vaccinated mice. Splenocytes from primary M. tuberculosis-infected mice conferred marginally higher protection than did those from BCG-vaccinated mice. Serum transfer did not protect against reinfection in either group. Our data emphasize that natural infection with M. tuberculosis and vaccination with BCG do not differ in their capacity to induce protective immunity against tuberculosis and support the notions that reinfection contributes to the development of active disease and that any novel vaccine against tuberculosis has to perform better than both vaccination with BCG and immunity evoked by natural infection.

Citing Articles

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.

Qin L, Zhang G, Wu Y, Yang Y, Zou Z Cancer Immunol Immunother. 2024; 73(6):103.

PMID: 38630135 PMC: 11024071. DOI: 10.1007/s00262-024-03693-7.


Exposure to Mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection.

Mai D, Jahn A, Murray T, Morikubo M, Lim P, Cervantes M PLoS Pathog. 2024; 20(1):e1011871.

PMID: 38236787 PMC: 10796046. DOI: 10.1371/journal.ppat.1011871.


Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model.

Plumlee C, Barrett H, Shao D, Lien K, Cross L, Cohen S PLoS Pathog. 2023; 19(11):e1011825.

PMID: 38011264 PMC: 10703413. DOI: 10.1371/journal.ppat.1011825.


Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections.

Moreno-Molina M, Shubladze N, Khurtsilava I, Avaliani Z, Bablishvili N, Torres-Puente M Nat Commun. 2021; 12(1):2716.

PMID: 33976135 PMC: 8113332. DOI: 10.1038/s41467-021-22705-z.


Cutting Edge: Bacillus Calmette-Guérin-Induced T Cells Shape Infection before Reducing the Bacterial Burden.

Delahaye J, Gern B, Cohen S, Plumlee C, Shafiani S, Gerner M J Immunol. 2019; 203(4):807-812.

PMID: 31308091 PMC: 6684453. DOI: 10.4049/jimmunol.1900108.